A prospective pilot trial of the health data monitoring system without educational content for patients with hypertension

Hypertens Res. 2024 Feb;47(2):529-532. doi: 10.1038/s41440-023-01510-9. Epub 2023 Nov 28.

Abstract

In Japan, a hypertension treatment aid application (CureApp Co., Ltd.) with educational content on hypertension was the first in the world to show significant blood pressure (BP) reduction in hypertensive patients in 2021. Omron Healthcare Corporation and I developed the Health data Monitoring System (HMS) without educational content, which allows patients to check their home BP values periodically and allows physicians to check their home BP data before the hospital visit. As a pilot study, nineteen patients with hypertension used HMS for six months. The percentage of patients achieving their antihypertensive goal increased from 16% to 37%. Mean home systolic BP decreased from 138.1 ± 11.8 mmHg to 130.2 ± 7.8 mmHg. The increase in number of home BP measurements was significantly associated with the amount of homed systolic BP reduction in men. In conclusion, HMS without educational content may be an adjunct to hypertension treatment.

Keywords: Application; Blood pressure; Digital hypertension; Hypertension.

MeSH terms

  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / physiology
  • Blood Pressure Monitoring, Ambulatory
  • Humans
  • Hypertension* / drug therapy
  • Hypotension*
  • Male
  • Pilot Projects
  • Prospective Studies

Substances

  • Antihypertensive Agents